Tourmaline Bio Inc (TRML)

Currency in USD
18.85
+0.25(+1.33%)
Real-time Data·
TRML Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
TRML is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.7019.02
52 wk Range
11.5629.79
Key Statistics
Prev. Close
18.6
Open
18.83
Day's Range
18.7-19.02
52 wk Range
11.56-29.79
Volume
13.69K
Average Volume (3m)
285.67K
1-Year Change
21.81%
Book Value / Share
10.9
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TRML Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
55.70
Upside
+195.49%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Tourmaline Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Tourmaline Bio Inc Company Profile

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company’s development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.

Compare TRML to Peers and Sector

Metrics to compare
TRML
Peers
Sector
Relationship
P/E Ratio
−5.8x−4.5x−0.5x
PEG Ratio
−0.200.000.00
Price/Book
1.7x2.2x2.6x
Price / LTM Sales
-9.1x3.2x
Upside (Analyst Target)
203.8%143.8%43.8%
Fair Value Upside
Unlock12.2%5.1%Unlock

Analyst Ratings

11 Buy
0 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 55.70
(+195.49% Upside)

Earnings

Latest Release
May 02, 2025
EPS / Forecast
-0.89 / -0.86
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TRML Income Statement

FAQ

What Is the Tourmaline Bio (TRML) Stock Price Today?

The Tourmaline Bio stock price today is 18.85

What Stock Exchange Does Tourmaline Bio Trade On?

Tourmaline Bio is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Tourmaline Bio?

The stock symbol for Tourmaline Bio is "TRML."

What Is the Tourmaline Bio Market Cap?

As of today, Tourmaline Bio market cap is 484.23M.

What Is Tourmaline Bio's Earnings Per Share (TTM)?

The Tourmaline Bio EPS (TTM) is -3.22.

From a Technical Analysis Perspective, Is TRML a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Tourmaline Bio Stock Split?

Tourmaline Bio has split 1 times.

How Many Employees Does Tourmaline Bio Have?

Tourmaline Bio has 74 employees.

What is the current trading status of Tourmaline Bio (TRML)?

As of 18 Jul 2025, Tourmaline Bio (TRML) is trading at a price of 18.85, with a previous close of 18.60. The stock has fluctuated within a day range of 18.70 to 19.02, while its 52-week range spans from 11.56 to 29.79.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.